Cointime

CellNovo

company

About

CellNovo is a medical device company developing a wireless therapeutic system for diabetic patients.

  • 51 - 100

Highlights

Total Funding Amount
€25M
Funding Rounds
2
Investors
2

Details

Last Funding Type
Post-IPO Debt
Last Funding Money Raised
€20M
Industries
Biotechnology,Diabetes,Health Care,Medical Device
Founded date
Jan 1, 2002
Number Of Employee
51 - 100
Operating Status
Active

CellNovo believe that conventional diabetes care technology is stuck in the past, and that it has failed to put first the needs and wants of patients who have to live with the condition and the daily demands of its treatment. Those with diabetes should be put back in control, and they should live a life that is as unaffected as possible by the need to manage their condition.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
€25M
CellNovo has raised a total of €25M in funding over 2 rounds. Their latest funding was raised on Jul 10, 2017 from a Post-IPO Debt round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jul 10, 2017 Post-IPO Debt €20M 1 European Investment Bank — Detail
May 10, 2017 Post-IPO Debt €5M 1 Kreos Capital — Detail

Investors

Number of Lead Investors
Number of Investors
2
2
CellNovo is funded by 2 investors. European Investment Bank and Kreos Capital are the most recent investors.
Investor Name Lead Investor Funding Round
European Investment Bank Yes Post-IPO Debt
Kreos Capital Yes Post-IPO Debt
Cointime
Содержание
компания